| # | Drug | Count |
|---|---|---|
| 0 | AMLODIPINE | 6 |
| 1 | CYCLOPHOSPHAMIDE | 5 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 5 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 5 |
| 4 | METHOTREXATE | 5 |
| 5 | METHOTREXATE SODIUM | 5 |
| 6 | APIXABAN | 4 |
| 7 | AZATHIOPRINE | 4 |
| 8 | BISOPROLOL FUMARATE | 4 |
| 9 | DURVALUMAB | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TREOSULFAN | 3 | 0.0011 |
| 1 | TREMELIMUMAB | 4 | 0.0009 |
| 2 | STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM | 1 | 0.0007 |
| 3 | ENFORTUMAB VEDOTIN | 4 | 0.0005 |
| 4 | CALCIUM GLUCONATE | 3 | 0.0002 |
| 5 | DURVALUMAB | 4 | 0.0002 |
| 6 | PEGASPARGASE | 2 | 0.0002 |
| 7 | MITOXANTRONE HYDROCHLORIDE | 1 | 0.0002 |
| 8 | ALEMTUZUMAB | 3 | 0.0002 |
| 9 | LABETALOL | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Ligand-1 Blocker [EPC] | 4 | 0.0002 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |
| 2 | Asparagine-specific Enzyme [EPC] | 2 | 0.0001 |
| 3 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 4 | CTLA-4-directed Blocking Antibody [EPC] | 4 | 0.0001 |
| 5 | Purine Antimetabolite [EPC] | 4 | 0.0000 |
| 6 | Central alpha-2 Adrenergic Agonist [EPC] | 2 | 0.0000 |
| 7 | Angiotensin Converting Enzyme Inhibitor [EPC] | 4 | 0.0000 |
| 8 | Alkylating Drug [EPC] | 5 | 0.0000 |
| 9 | Thiazide Diuretic [EPC] | 4 | 0.0000 |